David Fernández Bleda, global head EHS operations and Pere Hernandez, global EHS API projects manager, ESTEVE CDMO explore the human side of HPAPI safety.
Joel Pike, senior global product manager, Avantor looks at the role of excipients in enabling the shift from intravenous to subcutaneous drug delivery.
Brenntag has announced a new exclusive distribution partnership with Indovinya Belgium N.V., part of the Indorama Group, covering polyethylene glycols (Macrogols) and polysorbates for pharmaceutical and nutraceutical applications.
Onyx Scientific has announced an investment of more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities, and increase capacity for commercial active pharmaceutical ingredient (API) production at the company’s Sunderland UK facility.
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8th October), and demonstrate how they solve diverse drug delivery challenges.
A European consortium has demonstrated a new way of manufacturing pharmaceutical ingredients that could help reduce dependence on centralised production, strengthen medicine supply chains and accelerate the industrialisation of critical drugs.
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8th October), and demonstrate how they solve diverse drug delivery challenges.
Dr. Janik Kaufmann, technical sales specialist Oligonucleotides, Hongene Biotech, looks at why chemoenzymatic technologies are moving into the spotlight.
A European consortium has demonstrated a new way of manufacturing pharmaceutical ingredients that could help reduce dependence on centralised production, strengthen medicine supply chains and accelerate the industrialisation of critical drugs.
